The Digitome: a platform for enabling rapid decentralization, personalization and recruitment for clinical trials | eyeforpharma

FREE WEBINAR | November 12th, 2019

3pm London / 4pm Paris / 10am New York / 7am San Francisco

“Today, medicines work well in only a fraction of a target patient population. Not only is this a disservice to hundreds of thousands of patients, it is also a huge contributing factor to the poor performance and failure of many clinical trials.”

In Partnership With:

This is going to be an interesting discussion regarding #DigitalClinincalTrials, #DigitalTrials.

Discover the algorithms that canvass different datasets to help find the necessary unique patient populations’ with the aim of creating personalised trials.

You can find out how to virtually connect eligible patients for pre-screening’ as well as how to use ‘telemedicine to further reduce on-site screening failures‘.

Learn how to ‘improve trial design, site selection and predict results‘ through using ‘Machine Learning‘ – adjust your inclusion and exclusion criteria accordingly.

The big picture: a new trend in the use of digital biomarkers to build a picture of your own unique homeostasis and relying on technology to determine when deviations need attention

Discover the #algorithms that ‘canvass different #datasets’ to help find the necessary ‘unique #patientpopulations’ with the aim of creating #personalisedtrials. @eyeforpharma webinar #digitaltrials

Panelists include:

  • Michelle Longmire | CEO – Medable

  • Adama Ibrahim | Associate Director, POC, Global Clinical Operations – Biogen

Moderator: Paul Simms Chairman – eyeforpharma

Sign up now to be part of a very exciting session!

Learn how to ‘improve #trialdesign, site selection and #predictresults’ through using ‘#MachineLearning’ – adjust your inclusion and exclusion criteria accordingly. @eyeforpharma webinar #digitaltrials

eyeforpharma Ltd by Reuters Events, headquartered at 7-9 Fashion Street, London, E1 6PX, United Kingdom. A registered company in England and Wales: 09823909.

FibroFlutters supporting eyeforpharma by Reuters as Patient, Health, Research & Pharma advocates, we are non-commercial.